Global life sciences firm, Schering-Plough, announced last night an investment in early drug discovery technologies supporting its global R&D activities. The company is investing a total of $60 million across three of its worldwide locations in Scotland, US and the Netherlands. Half of the investment is to be spent at its Newhouse facility in Scotland.
for more details
http://www.schering-plough.co.uk/spuk/index.jsp
No comments:
Post a Comment